Form 4 for RCEL AVITA Medical, Inc.
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-28 · accession 0000950170-24-022050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-28 | 2024-02-28 | RCEL | O'Toole David D | CFO | P - Purchase | $17.39 | +1,250 | 18.7K | +7% | +$21.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | P | A | 1,000 | $17.38 | 18,484 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-28 | P | A | 250 | $17.43 | 18,734 | D | — | — |